medigraphic.com

2019, Número 4

<< Anterior Siguiente >>

Cir Cir 2019; 87 (4)


Factores predictores para el diagnóstico de la colecistitis aguda gangrenosa

Real-Noval H, Fernández-Fernández J, Soler-Dorda G

Idioma: Español
Referencias bibliográficas: 32
Paginas: 443-449
Archivo PDF: 242.49 Kb.


RESUMEN

Antecedentes: La colecistitis aguda gangrenosa (CG) debe tratarse precozmente por su alto riesgo de morbimortalidad. Objetivo: Identificar factores clínicos, analíticos o ecográficos que permitan diagnosticar CG preoperatoriamente. Método: Estudio de cohorte retrospectiva en el Hospital de Laredo (Cantabria, España), entre 2015 y 2017, de pacientes con diagnóstico de colecistitis aguda que hayan sido intervenidos. Se clasificó a los pacientes en dos grupos según el diagnóstico anatomopatológico: CG y colecistitis no gangrenosa (CNG). Se compararon las características demográficas, la comorbilidad, los datos analíticos y los datos ecográficos. Resultados: Fueron operados 115 pacientes, de los cuales 32 tenían CG y 83 tenían CNG. Los pacientes con CG muestran unos valores más altos de índice de neutrófilos/linfocitos (p = 0.042) y de proteína C reactiva (PCR) (p ‹ 0.0001). La colecistitis alitiásica se asoció con mas frecuencia a la CG (24.1 vs. 7.0%; p ‹ 0.005). En el estudio multivariable, solo la PCR se muestra significativa. La PCR mostró un área bajo la curva ROC de 0.872, (intervalo de confianza del 95%: 0.797-0.946). Un punto de corte de PCR de 15.25 mg/dl tuvo una alta sensibilidad (90.6%) y un alto valor predictivo negativo (95%). Conclusión: La PCR ayuda a identificar a los pacientes con CG para indicar una intervención quirúrgica precoz.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Badia JM, Nve E, Jimeno J, Guirao X, Figueras J, Arias-Díaz J. Tratamiento quirúrgico de la colecistitis aguda. Resultados de una encuesta a los cirujanos españoles. Cirugía Española. 2014;92:517-24.

  2. Asai K, Watanabe M, Kusachi S, Matsukiyo H, Saito T, Ishii T, et al. Evaluating the timing of laparoscopic cholecystectomy for acute cholecystitis in an experienced center based on propensity score matching. Asian J Endosc Surg. 2017;10:166-72.

  3. Borzellino G, Steccanella F, Mantovani W, Genna M. Predictive factors for the diagnosis of severe acute cholecystitis in an emergency setting. Surg Endosc. 2013;27:3388-95.

  4. Fagan SP, Awad SS, Rahwan K, Hira K, Aoki N, Itani KM, et al. Prognostic factors for the development of gangrenous cholecystitis. Am J Surg. 2003;186:481-5.

  5. Nguyen L, Fagan SP, Lee TC, Aoki N, Itani KM, Berger DH, et al. Use of a predictive equation for diagnosis of acute gangrenous cholecystitis. Am J Surg. 2004;188:463-6.

  6. Aydin C, Altaca G, Berber I, Tekin K, Kara M, Titiz I. Prognostic parameters for the prediction of acute gangrenous cholecystitis. J Hepatobiliary Pancreat Surg. 2006;13:155-9.

  7. Fry DE, Cox RA, Harbrecht PJ. Gangrene of the gallbladder: a complication of acute cholecystitis. South Med J. 1981;74 666-8.

  8. Ambe PC, Papadakis M, Zirngibl H. A proposal for a preoperative clinical scoring system for acute cholecystitis. J Surg Res. 2016;200:473-9.

  9. Yeh DD, Cropano C, Fagenholz P, King DR, Chang Y, Klein EN, et al. Gangrenous cholecystitis: deceiving ultrasounds, significant delay in surgical consult, and increased postoperative morbidity! J Trauma Acute Care Surg. 2015;79 812-6.

  10. Bennett GL, Rusinek H, Lisi V, Israel GM, Krinsky GA, Slywotzky CM, et al. CT findings in acute gangrenous cholecystitis. AJR Am J Roentgenol. 2002;178:275-81.

  11. Lee SK, Lee SC, Park JW, Kim S-J. The utility of the preoperative neutrophil- to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg. 2014;14:100.

  12. Beliaev AM, Angelo N, Booth M, Bergin C. Evaluation of neutrophil- to-lymphocyte ratio as a potential biomarker for acute cholecystitis. J Surg Res. 2017;209:93-101.

  13. Yuzbasioglu Y, Duymaz H, Tanrikulu CS, Halhalli HC, Koc MO, Tandoğan M, et al. Role of procalcitonin in evaluation of the severity of acute cholecystitis. Eurasian J Med. 2016;48:162-6.

  14. Mok KWJ, Reddy R, Wood F, Turner P, Ward JB, Pursnani KG, et al. Is C-reactive protein a useful adjunct in selecting patients for emergency cholecystectomy by predicting severe/gangrenous cholecystitis? Int J Surg. 2014;12:649-53.

  15. Beliaev AM, Marshall RJ, Booth M. C-reactive protein has a better discriminative power than white cell count in the diagnosis of acute cholecystitis. J Surg Res. 2015;198:66-72.

  16. Yokoe M, Hata J, Takada T, Strasberg SM, Asburn HJ, Wakabayashi G, et al. Tokyo Guidelines 2018. Diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018; 25:41-54.

  17. Merriam LT, Kanaan SA, Dawes LG, Angelos P, Prystowsky JB, Rege RV, et al. Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy. Surgery. 1999;126 680-5; discussion 685-6.

  18. Ambe PC, Christ H, Wassenberg D. Does the Tokyo guidelines predict the extent of gallbladder inflammation in patients with acute cholecystitis? A single center retrospective analysis. BMC Gastroenterol. 2015;15:142.

  19. Bourikian S, Anand RJ, Aboutanos M, Wolfe LG, Ferrada P. Risk factors for acute gangrenous cholecystitis in emergency general surgery patients. Am J Surg. 2015;210:730-3.

  20. Stefanidis D, Sirinek KR, Bingener J. Gallbladder perforation: risk factors and outcome. J Surg Res. 2006;131:204-8.

  21. Nikfarjam M, Harnaen E, Tufail F, Muralidharan V, Fink MA, Starkey G, et al. Sex differences and outcomes of management of acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2013;23:61-5.

  22. Teefey SA, Dahiya N, Middleton WD, Bajaj S, Dahiya N, Ylagan L, et al. Acute cholecystitis: do sonographic findings and WBC count predict gangrenous changes? AJR Am J Roentgenol. 2013;200:363-9.

  23. Lee SK, Lee SC, Park JW, Kim SJ. The utility of the preoperative neutrophil- to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg. 2014;14:100.

  24. Beliaev AM, Angelo N, Booth M, Bergin C. Evaluation of neutrophil- to-lymphocyte ratio as a potential biomarker for acute cholecystitis. J Surg Res. 2017;209 93-101.

  25. Nikfarjam M, Niumsawatt V, Sethu A, Fink MA, Muralidharan V, Starkey G, et al. Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis. HPB (Oxford). 2011;13:551-8.

  26. Jessica Mok KW, Goh YL, Howell LE, Date RS. Is C-reactive protein the single most useful predictor of difficult laparoscopic cholecystectomy or its conversion? A pilot study. J Minim Access Surg. 2016;12:26-32.

  27. Wevers KP, van Westreenen HL, Patijn GA. Laparoscopic cholecystectomy in acute cholecystitis: C-reactive protein level combined with age predicts conversion. Surg Laparosc Endosc Percutan Tech. 2013;23:163-6.

  28. Wu C, Chen C, Wang C, Wong Y, Wang L, Huang C, et al. Discrimination of gangrenous from uncomplicated acute cholecystitis: accuracy of CT findings. Abdom Imaging. 2011;36:174-8.

  29. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg. 1998;64:471-5.

  30. Yeh D, Cropano C, Fagenholz P, King D, Chang Y, Klein E, et al. Gangrenous cholecystitis: deceiving ultrasounds, significant delay in surgical consult, and increased postoperative morbidity. J Trauma Acute Care Surg. 2015;79:812-6.

  31. Csendes A, Burdiles P, Maluenda F, Diaz JC, Csendes P, Mitru N. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg. 1996;131:389.

  32. Fitzgibbons RJ Jr, Tseng A, Wang H, Ryberg A, Nguyen N, Sims KL. Acute cholecystitis. Does the clinical diagnosis correlate with the pathological diagnosis? Surg Endosc. 1996;10:1180-4.




2020     |     www.medigraphic.com